Authors
Bosov E.D., Bogdanova V.A., Saraeva S.N.
Pirogov National Medical and Surgical Center, Moscow
Abstract
Backgraund: Age-related macular degeneration (AMD) is one of the main causes of deterioration and irreversible loss of visual acuity in patients. It is most severe in the neovascular form of AMD. The development of submacular hemorrhage is an unfavorable prognostic sign.
Aims: To determine the effectiveness of minimally invasive personalized surgical treatment of submacular hemorrhages (SMH) against the background of neovascular age-related macular degeneration (nАMD).
Materials and methods: The data of 77 people (77 eyes) were processed in the study. Of these, 36 eyes had a small hemorrhage size, 22 had an average size, massive size was seen in 19 patients.
Results: A minimally invasive personalized approach to the treatment of subfoveal hemorrhages of various sizes has been proposed and applied.
Conclusions: Improvement of vision with an appropriate treatment strategy is regardless of the size of the SMH. After performing vitreoretinal intervention, subsequent therapy with angiogenesis inhibitors is required, in accordance with the etiological factor.
Keywords: submacular hemorrhage, fibrinolytic, pneumodislocation, age-related macular degeneration.
References
1. Thomas CJ, Mirza RG, Gill MK. Age-Related Macular Degeneration. Med Clin North Am. 2021 May;105(3):473-491. doi: 10.1016/j.mcna.2021.01.003. Epub 2021 Apr 2. PMID: 33926642.
2. Hua R, Zhang M. Imaging Characteristics of Neovascular and Atrophic Pachychoroidal Spectrum Diseases. Front Med (Lausanne). 2022 Jul 4;9:891397. doi: 10.3389/fmed.2022.891397. PMID: 35860744; PMCID: PMC9289118.
3. Chang YS, Kim JH, Kim JW, Kim CG, Lee DW. Development of Submacular Hemorrhage in Neovascular Age-related Macular Degeneration: Influence on Visual Prognosis in a Clinical Setting. Korean J Ophthalmol. 2018 Oct;32(5):361-368. doi: 10.3341/kjo.2017.0095. PMID: 30311458; PMCID: PMC6182213.
4. Fayzrakhmanov RR, Shishkin MM, Bosov ED, Suhanova AV, Mironov AV. Pathomorphology of submacular hemorrhage (review). Saratov Journal of Medical Scientific Research 2021;17(1):28–32. (In Russ).
5. Yokoyama S, Kaga T, Kojima T, Orellana-Rios J, Smith RT, Ichikawa K. Treatment of old submacular hemorrhage by subretinal endoscopic surgery and intraoperative subretinal endoscopic findings. Am J Ophthalmol Case Rep. 2022 Feb 4;25:101393 [URL].
6. Jeong S, Park DG, Sagong M. Management of a Submacular Hemorrhage Secondary to Age-Related Macular Degeneration: A Comparison of Three Treatment Modalities. J Clin Med. 2020 Sep 24;9(10):3088. doi: 10.3390/jcm9103088. PMID: 32987903; PMCID: PMC7601376.
7. Patent RUS № 2788357/ 17.01.2023. Byul. № 2. Fayzrakhmanov RR., Bosov ED., Karpov GO., Bogdanova VA. Sposob maloinvazivnoi korrekcii submakulyarnih krovoizliyanii. (In Russ.)
8. Certificate of state registration of the computer program No. 2023612728 Russian Federation. System for calculating the volume of fibrinolytic infusion solution for surgical treatment of submacular hemorrhages : No. 2023611290 : application 25.01.2023 : publ. 07.02.2023 / E. D. Bosov, R. R. Fayzrakhmanov, I. I. Tumanov. – EDN TZFUWJ.
